Lymphocyte-to-monocyte ratio can predict mortality in pancreatic adenocarcinoma

Table 2 Clinical variables in patients with high and low lymphocyte-to-monocyte ratio

	LMR ≤ 2.05 (n = 50)	LMR > 2.05 (n = 43)	P value
Chemoradiation	20	21	0.4
Surgery	7	14	0.05
Stent	19	16	1.0
Stage			0.2
Stage 1	0	1
Stage 2	8	14
Stage 3	8	5
Stage 4	34	23
Location			0.4
Head	35	27
Body	3	6
Tail	9	6
Race			0.05
White	36	25
Black	11	18
Other	3	0
CEA (± SEM)	1075 ± 1041	884 ± 868	0.9
CA 19-9 (± SEM)	24957 ± 17470	10162 ± 3448	0.4
Age (± SEM)	66.6 ± 1.2	65.3 ± 1.4	0.5
Weight (± SEM)	79.3 ± 2.2	82.2 ± 2.5	0.4
Alcohol	27	24	1.0
Tobacco	38	34	0.8

LMR: Lymphocyte-to-monocyte ratio.